DK133404B - Fremgangsmade til fremstilling af et stabilt lyofiliseret antigen- eller antigen-protein-konjugat-belagt erythrocytpreparat - Google Patents

Fremgangsmade til fremstilling af et stabilt lyofiliseret antigen- eller antigen-protein-konjugat-belagt erythrocytpreparat

Info

Publication number
DK133404B
DK133404B DK112174AA DK112174A DK133404B DK 133404 B DK133404 B DK 133404B DK 112174A A DK112174A A DK 112174AA DK 112174 A DK112174 A DK 112174A DK 133404 B DK133404 B DK 133404B
Authority
DK
Denmark
Prior art keywords
antigen
lyofilized
procedure
stable
making
Prior art date
Application number
DK112174AA
Other languages
English (en)
Other versions
DK133404C (da
Inventor
J Spona
M Topert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK133404B publication Critical patent/DK133404B/da
Application granted granted Critical
Publication of DK133404C publication Critical patent/DK133404C/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK112174A 1973-03-02 1974-03-01 Fremgangsmade til fremstilling af et stabilt lyofiliseret antigen- eller antigen-protein-konjugat-belagt erythrocytpreparat DK133404C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732310964 DE2310964A1 (de) 1973-03-02 1973-03-02 Antigen- bzw. antigen-proteinkonjugatbeschichtete erythrocytenpraeparation

Publications (2)

Publication Number Publication Date
DK133404B true DK133404B (da) 1976-05-10
DK133404C DK133404C (da) 1976-10-04

Family

ID=5873879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK112174A DK133404C (da) 1973-03-02 1974-03-01 Fremgangsmade til fremstilling af et stabilt lyofiliseret antigen- eller antigen-protein-konjugat-belagt erythrocytpreparat

Country Status (10)

Country Link
US (1) US3987159A (da)
JP (1) JPS49134827A (da)
BE (1) BE811782A (da)
CH (1) CH591695A5 (da)
DD (1) DD110357A5 (da)
DE (1) DE2310964A1 (da)
DK (1) DK133404C (da)
FR (1) FR2219973B1 (da)
GB (1) GB1460522A (da)
NL (1) NL7402791A (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145185A (en) * 1977-02-25 1979-03-20 Research Triangle Institute Reagents for screening tests and bioassay of von Willebrand's factor (platelet aggregating factor) in blood plasmas
US4096237A (en) * 1977-03-14 1978-06-20 Hoffmann-La Roche Inc. Immunoassay for β-endorphin
US4320111A (en) * 1977-06-14 1982-03-16 American Home Products Corporation Immunologic compositions methods of preparation and use
US4234569A (en) * 1978-10-04 1980-11-18 The Johns Hopkins University Production of aldehyde-treated allergen-containing substances
GB2055847A (en) * 1979-07-30 1981-03-11 Bull F G Process for the production of carrier particles
JPS5642142A (en) * 1979-08-31 1981-04-20 Amano Pharmaceut Co Ltd Removing method for nonspecific reaction inhibiting action in immunity measuring method
US4259207A (en) * 1979-09-19 1981-03-31 American Hospital Supply Corporation Suspending medium for immunologic reactions
EP0039195B1 (en) * 1980-04-28 1986-06-18 Montefiore Hospital and Medical Center Antibody detection process
JPS5926065A (ja) * 1982-08-02 1984-02-10 Green Cross Corp:The ヒト尿カリクレイン測定用試薬
FR2534030A1 (fr) * 1982-10-01 1984-04-06 Pasteur Institut Procede de detection et de dosage d'une substance biologique par erythroadsorption
US4608246A (en) * 1983-03-10 1986-08-26 Immucor, Inc. Testing for a blood group immunological reaction
JPS59192961A (ja) * 1983-04-15 1984-11-01 Green Cross Corp:The 血液凝固第「じ」因子測定用試薬
FR2577048B1 (fr) * 1985-02-05 1988-05-06 Pasteur Institut Reactif pour le dosage par hemagglutination des anticorps contre les toxines bacteriennes, procede de preparation et son application
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
JPS63159763A (ja) * 1986-12-24 1988-07-02 Fujirebio Inc 逆受身凝集反応試薬
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
IL90188A0 (en) * 1988-05-18 1989-12-15 Cryopharm Corp Process and medium for the lyophilization of erythrocytes
US5102788A (en) * 1988-11-21 1992-04-07 Hygeia Sciences, Inc. Immunoassay including lyophilized reactant mixture
WO1991018504A1 (en) * 1990-05-25 1991-12-12 Cryopharm Corporation Process for lyophilizing cells, cell-like materials and platelets in a mixture of biocompatible amphipathic polymers
US6884573B2 (en) * 2001-08-31 2005-04-26 The University Of North Carolina At Chapel Hill Fixed dried red blood cells and method of use
US7560283B2 (en) * 2006-01-27 2009-07-14 Bio-Rad Laboratories, Inc. Storage-stable cellular whole blood composition containing elevated amounts of D-dimer
US20080280310A1 (en) * 2007-05-09 2008-11-13 Louis Panagopoulos Testing for Blood Group Immunological Reaction Without the Use of Anti-Human Globulin
RU2452501C2 (ru) * 2010-08-31 2012-06-10 Александр Владимирович Балюра Сенситин для эритроцитарного диагностикума для диагностики злокачественных новообразований и способ его получения, эритроцитарный диагностикум для диагностики злокачественных новообразований и способ его получения и способ диагностики наличия злокачественных новообразований с использованием указанного эритроцитарного диагностикума
US10793327B2 (en) 2017-10-09 2020-10-06 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
EP3938742A1 (en) 2019-03-14 2022-01-19 Terumo BCT Biotechnologies, LLC Multi-part lyophilization container and method of use
RU2714305C1 (ru) * 2019-08-19 2020-02-14 Федеральное государственное бюджетное научное учреждение "Федеральный аграрный научный центр Республики Дагестан" Способ изготовления бруцеллезного эритроцитарного антигена для реакции непрямой гемагглютинации (РНГА)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3057775A (en) * 1959-02-04 1962-10-09 Champion Co Embalming composition
US3096250A (en) * 1959-11-30 1963-07-02 Indiana University Foundation Novel particulate antigens and process
NL126572C (da) * 1966-03-24
GB1244344A (en) * 1967-11-13 1971-08-25 Abbott Lab Hemagglutination testing procedure employing stabilized and potentiated erythrocytes and a method for their preparation
US3553310A (en) * 1967-12-28 1971-01-05 Miles Lab Immunologically reactive particles
IL34960A (en) * 1970-07-20 1974-11-29 Rafa Labor Ltd A method for the determination of pregnancy and a serodiagnostic composition therefor

Also Published As

Publication number Publication date
FR2219973B1 (da) 1976-10-08
CH591695A5 (da) 1977-09-30
DE2310964A1 (de) 1974-09-05
GB1460522A (en) 1977-01-06
US3987159A (en) 1976-10-19
BE811782A (fr) 1974-09-02
NL7402791A (da) 1974-09-04
JPS49134827A (da) 1974-12-25
FR2219973A1 (da) 1974-09-27
DD110357A5 (da) 1974-12-12
DK133404C (da) 1976-10-04

Similar Documents

Publication Publication Date Title
DK133404C (da) Fremgangsmade til fremstilling af et stabilt lyofiliseret antigen- eller antigen-protein-konjugat-belagt erythrocytpreparat
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK113083D0 (da) Fremgangsmade til fremstilling af et antistofkonjugat
DK152334C (da) Fremgangsmaade til fremstilling af et intravenoest indgiveligt, pyrogenfrit, lagringsstabilt serumproteinpraeparat
DK149968C (da) Fremgangsmaade til immunkemisk maengdebestemmelse af et antigen
DK440977A (da) Fremgangsmaade til fremstilling af et funktionelt protein
DK271677A (da) Fremgangsmade til fremstilling af et farmaceutisk indsetningspreparat
DK29576A (da) Fremgangsmade til fremstilling af peptider
SE431800B (sv) Forfarande for framstellning av eventuellt med antigen belagda stabila, lyofiliserbara erytrocyter och anvendningen av dessa belagda erytrocyten som reagens
SE7609766L (sv) Forfarande for framstellning av nytt proteinkoncentrat
DK161026C (da) Analogifremgangsmaade til fremstilling af antigenderivater
DK157781C (da) Fremgangsmaade til fremstilling af et tretinoinholdigt gelpraeparat til lokal applikation
DK141586C (da) Fremgangsmaade til fremstilling af et humleoliepraeparat
DK203879A (da) Fremgangsmaade til fremstilling af en farmaceutisk doseringskomponent
DK273376A (da) Fremgangsmade til fremstilling af 11-desoxy-16-aryloxy-omega-pentanorprostaglandiner
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK98076A (da) Fremgangsmade til fremstilling af et farmaceutisk preparat
DK97476A (da) Fremgangsmade til fremstilling af pyrimidinyl-urinstoffer
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
DK34276A (da) Fremgangsmade til fremstilling af naphthylderivater
DK371477A (da) Fremgangsmaade til fremstilling af et praeparat
DK137924C (da) Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner
DK142147C (da) Fremgangsmaade til rensning af serumprotein-konjugater
NO139845C (no) Fremgangsmaate til fremstilling av et kjoettlignende proteinnaeringsmiddel
DK485176A (da) Fremgangsmade til fremstilling af pyridylurinstoffer